1. Home
  2. CLDX vs GTY Comparison

CLDX vs GTY Comparison

Compare CLDX & GTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLDX
  • GTY
  • Stock Information
  • Founded
  • CLDX 1983
  • GTY 1955
  • Country
  • CLDX United States
  • GTY United States
  • Employees
  • CLDX N/A
  • GTY N/A
  • Industry
  • CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • GTY Real Estate
  • Sector
  • CLDX Health Care
  • GTY Finance
  • Exchange
  • CLDX Nasdaq
  • GTY Nasdaq
  • Market Cap
  • CLDX 1.8B
  • GTY 1.8B
  • IPO Year
  • CLDX 2008
  • GTY N/A
  • Fundamental
  • Price
  • CLDX $25.77
  • GTY $32.36
  • Analyst Decision
  • CLDX Buy
  • GTY Buy
  • Analyst Count
  • CLDX 8
  • GTY 3
  • Target Price
  • CLDX $64.83
  • GTY $33.33
  • AVG Volume (30 Days)
  • CLDX 992.8K
  • GTY 217.4K
  • Earning Date
  • CLDX 11-06-2024
  • GTY 02-12-2025
  • Dividend Yield
  • CLDX N/A
  • GTY 5.83%
  • EPS Growth
  • CLDX N/A
  • GTY N/A
  • EPS
  • CLDX N/A
  • GTY 1.16
  • Revenue
  • CLDX $9,976,000.00
  • GTY $198,017,000.00
  • Revenue This Year
  • CLDX N/A
  • GTY N/A
  • Revenue Next Year
  • CLDX N/A
  • GTY $9.68
  • P/E Ratio
  • CLDX N/A
  • GTY $27.81
  • Revenue Growth
  • CLDX 128.55
  • GTY 9.20
  • 52 Week Low
  • CLDX $22.93
  • GTY $25.70
  • 52 Week High
  • CLDX $53.18
  • GTY $33.85
  • Technical
  • Relative Strength Index (RSI)
  • CLDX 45.64
  • GTY 53.90
  • Support Level
  • CLDX $24.48
  • GTY $31.82
  • Resistance Level
  • CLDX $26.66
  • GTY $32.64
  • Average True Range (ATR)
  • CLDX 1.19
  • GTY 0.46
  • MACD
  • CLDX 0.03
  • GTY -0.05
  • Stochastic Oscillator
  • CLDX 35.73
  • GTY 30.79

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.

About GTY Getty Realty Corporation

Getty Realty Corp is the real estate investment trust in the U.S. specializing in the acquisition, financing, and development of convenience, automotive, and other single tenant retail real estate. The company's portfolio includes convenience stores, car washes, automotive service centers (gasoline and repair, oil and maintenance, tire and battery, collision), automotive parts retailers, and certain other freestanding retail properties, including drive-thru quick service restaurants. It generates majority of the revenue in the form of rental income.

Share on Social Networks: